Preliminary microbiological and pharmacological evaluation of a semisynthetic kasugamycin, BL-A 2.
D000606:Amino Sugars / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000494:pharmacology* / Q000627:therapeutic use; D001419:Bacteria / Q000187:drug effects*; D007239:Infections / Q000188:drug therapy*; D007710:Klebsiella Infections / Q000188:drug therapy; D051379:Mice; D008826:Microbial Sensitivity Tests; D011552:Pseudomonas Infections / Q000188:drug therapy; D012481:Salmonella Infections, Animal / Q000188:drug therapy
D000606:Amino Sugars; D000900:Anti-Bacterial Agents